Boston Scientific (BSX)

SG&A Expenses

$1.80B

Quarterly · Period ending: · USD

BSX logo

BSX SG&A Expenses

Latest reported$1.80B
BSX Quarterly SG&A Expenses ($0.00 → $1.80B)
High-resolution chart · PNG

BSX sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
1,803,000,000
1,781,000,000
1,834,000,000
1,741,000,000
1,716,000,000
1,597,000,000
1,612,000,000
1,562,000,000
1,446,000,000
1,364,000,000
1,379,000,000
1,242,000,000
1,354,000,000
1,215,000,000
1,163,000,000
1,118,000,000
1,165,000,000
1,060,000,000
1,153,000,000
1,066,000,000
1,121,000,000
1,019,000,000
1,027,000,000
984,000,000
798,000,000
978,000,000
1,092,000,000
1,012,000,000
968,000,000
869,000,000
946,000,000
868,000,000
891,000,000
852,000,000
882,000,000
797,000,000
812,000,000
791,000,000
828,000,000
768,000,000
779,000,000
716,000,000
777,000,000
729,000,000
700,000,000
668,000,000
753,000,000
741,000,000
743,000,000
666,000,000
724,000,000
658,000,000
661,000,000
631,000,000
639,000,000
618,000,000
697,000,000
707,000,000
653,000,000
665,000,000
694,000,000
647,000,000
721,000,000
673,000,000
691,000,000
679,000,000
2,189,000,000
716,000,000
724,000,000
984,000,000
723,000,000
995,000,000
655,000,000
661,000,000
704,000,000
719,000,000
803,000,000
787,000,000
758,000,000
719,000,000
728,000,000
525,000,000
468,000,000
444,000,000
471,000,000
431,000,000
515,000,000
504,000,000
375,000,000
348,000,000
313,000,000
295,000,000
292,000,000
271,000,000
266,000,000
249,000,000
246,000,000
241,000,000
274,000,000
232,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.